Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2013
12/03/2013CA2326627C Nucleotide sequences for detecting enterohemorrhagic escherichia coli (ehec)
12/03/2013CA2213610C Ingap protein involved in pancreatic islet neogenesis
11/2013
11/29/2013CA2855922A1 Remote chemical assay classification
11/29/2013CA2835729A1 Method for measuring glycosylated hemoglobin, measurement reagent, and measurement kit
11/28/2013WO2013177581A2 Whole genome sequencing of a human fetus
11/28/2013WO2013177560A1 Microfluidic systems for particle trapping and separation
11/28/2013WO2013177538A2 Inhibition of delta-6 desaturase for the treatment of cardiometabolic disease
11/28/2013WO2013177525A2 Methods of nucleic acid fractionation and detection
11/28/2013WO2013177524A1 Nucleic acid amplification and use thereof
11/28/2013WO2013177518A1 Use of polymorphisms for identifying individuals at risk of developing autism
11/28/2013WO2013177510A1 Neuronal nicotinic receptor agonists for treating schizophrenia in patients with variants of comt gene
11/28/2013WO2013177465A1 Phenotypic integrated social search database and method
11/28/2013WO2013177429A2 Extreme pcr
11/28/2013WO2013177427A1 Brassica genomic assays
11/28/2013WO2013177426A2 Targeting the glutamine to pyruvate pathway for treatment of oncogenic kras-associated cancer
11/28/2013WO2013177386A1 Biomarkers for predicting response to tweak receptor (tweakr) agonist therapy
11/28/2013WO2013177329A1 Methods of detecting chlamydia and gonorrhea and of screening for infection/inflammation based on genomic copy number
11/28/2013WO2013177293A1 Trapping reagents for reactive metabolites screening
11/28/2013WO2013177277A1 Microbial concentration by utilizing poly-l-glutamic acid (pga) as a centrifugation bypass
11/28/2013WO2013177265A1 A QUANTITATIVE MULTIPLEX METHYLATION SPECIFIC PCR METHOD- cMethDNA, REAGENTS, AND ITS USE
11/28/2013WO2013177255A2 Chimeric luciferases
11/28/2013WO2013177245A2 Nano46 genes and methods to predict breast cancer outcome
11/28/2013WO2013177220A1 Methods of sample preparation
11/28/2013WO2013177206A2 Single-particle analysis of particle populations
11/28/2013WO2013177121A2 Identification and quantification of intact glycopeptides in complex samples
11/28/2013WO2013177086A1 Methods and processes for non-invasive assessment of genetic variations
11/28/2013WO2013177060A2 Methods and systems for monitoring, diagnosing, and treating chronic obstructive polmonary disease
11/28/2013WO2013177046A1 Methods and/or use of oligonucleotide conjugates for suppressing background due to cross-hybridization
11/28/2013WO2013176992A2 Methods and compositions for the diagnosis of sepsis using gamma peptide nucleic acids
11/28/2013WO2013176958A1 Methods and compositions for analyzing nucleic acid
11/28/2013WO2013176774A1 Microbiome markers and therapies for autism spectrum disorders
11/28/2013WO2013176767A1 Microfluidic devices, solid supports for reagents and related methods
11/28/2013WO2013176765A1 Compositions and methods relating to dennd1a variant 2 and polycystic ovary syndrome
11/28/2013WO2013176626A1 Method of identifying foetal erythroblast
11/28/2013WO2013176550A1 Screening method for micro-organisms and methods for the production of a product
11/28/2013WO2013176289A1 Biological molecule detection device, and, biological molecule detection method
11/28/2013WO2013176220A1 Regulation of circadian rhythm
11/28/2013WO2013176215A1 Separating agent
11/28/2013WO2013176136A1 Mycoplasma- and acholeplasma-detecting composition
11/28/2013WO2013175815A1 Method for suppressing errors in nucleic acid amplification reaction
11/28/2013WO2013175759A1 New revascularization cell group derived from human monocytes, and technique for inducing differentiation thereof
11/28/2013WO2013175365A1 Extraction control for rna
11/28/2013WO2013175364A1 Extraction control for dna
11/28/2013WO2013175318A2 Microbead agglutination based assays
11/28/2013WO2013175164A1 Characterization, classification and identification of microorganisms
11/28/2013WO2013174857A1 Method for differential treatment of nucleic acid contents of a sample, sample enrichment, kit and uses thereof
11/28/2013WO2013174834A1 Methods for diagnosing and treating focal segmental glomerulosclerosis
11/28/2013WO2013174637A1 Method for determining the risk of toxicity of sorafenib in cancer patients
11/28/2013WO2013174432A1 Method for the identification of the origin of a cancer of unknown primary origin by methylation analysis
11/28/2013WO2013174262A1 Cancer diagnosing method, reagent kit, and system
11/28/2013WO2013173993A1 Method and system for identifying types of twins
11/28/2013WO2013173912A1 Method of diagnosing cancer comprising detection of the methylation signature in the htert promoter
11/28/2013WO2013150454A3 System and method for detecting and analyzing amplified deoxyribonucleic acid
11/28/2013WO2013144722A3 Methods for detection of anti-cytomegalovirus neutralizing antibodies
11/28/2013WO2013085889A8 Identification and cloning of transmitted hepatitic c virus (hcv) genomes by single genome amplification
11/28/2013WO2012109600A3 Methods for forming mixed droplets
11/28/2013US20130318645 Methods and Vectors for Gene Targeting With Inducible Specific Expression
11/28/2013US20130318640 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives
11/28/2013US20130317317 Methods for treating barrett's metaplasia and esophageal adenocarcinoma
11/28/2013US20130317125 Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene
11/28/2013US20130317124 Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene
11/28/2013US20130317123 Large deletions in human pms2 gene and use thereof
11/28/2013US20130317087 Methods and compositions related to staufen 1 binding sites formed by duplexing alu elements
11/28/2013US20130317083 Non-coding transcripts for determination of cellular states
11/28/2013US20130317082 Methods and compositions for the diagnosis and treatment of cancer
11/28/2013US20130317056 Neuronal nicotinic agonists and methods of correlating comt snps
11/28/2013US20130317042 Method of Treating Ischemia/Reperfusion Injury
11/28/2013US20130317039 Inhibition of delta-6 desaturase for the treatment of cardiometabolic disease
11/28/2013US20130317030 Methods for Diagnosis of Cardiovascular Disease
11/28/2013US20130317006 Use of polymorphisms for identifying individuals at risk of developing autism
11/28/2013US20130316992 Breast cancer prognosis
11/28/2013US20130316935 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
11/28/2013US20130316933 Method for the diagnosis, prognosis and monitoring of muscular degeneration
11/28/2013US20130316930 Process and kit for determining in vitro the immune status of an individual
11/28/2013US20130316927 Microarray system with improved sequence specificity
11/28/2013US20130316926 Method for the monitoring of smoking cessation compliance and recovery, therapeutic intervention, and risk management
11/28/2013US20130316925 MicroRNA Expression in Human Peripheral Blood Microvesicles and Uses Thereof
11/28/2013US20130316924 Method for determining the neurodevelopmental toxicity of a compound in vitro
11/28/2013US20130316923 Methods for predicting anti-integrin antibody response
11/28/2013US20130316922 Quantitation and profiling of vaginal microflora
11/28/2013US20130316921 Methods for diagnosis of kawasaki disease
11/28/2013US20130316920 Nucleic Acid Analysis by Random Mixtures of Non-Overlapping Fragments
11/28/2013US20130316918 Model-based residual correction of intensities
11/28/2013US20130316917 Selective enrichment of nucleic acids
11/28/2013US20130316916 Classification of nucleic acid templates
11/28/2013US20130316915 Methods for determining absolute genome-wide copy number variations of complex tumors
11/28/2013US20130316914 Methods And Devices For Sequencing Nucleic Acids In Smaller Batches
11/28/2013US20130316913 Isolation of CpG Islands by Thermal Segregation and Enzymatic Selection-Amplification Method
11/28/2013US20130316912 Polymerase enzyme substrates with protein shield
11/28/2013US20130316911 Methods and compositions for screening and treating developmental disorders
11/28/2013US20130316441 Genetic analyzer
11/28/2013US20130316394 Viability staining method
11/28/2013US20130316393 Microbial detection article having a water-absorbent filter assembly
11/28/2013US20130316386 Test element, test kit, test device, and test method
11/28/2013US20130316385 Methods and compositions for cell-proliferation-related disorders
11/28/2013US20130316369 Method for detecting escherichia coli
11/28/2013US20130316362 Genotoxic testing
11/28/2013US20130316360 Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome
11/28/2013US20130316359 Method for determining cancer prognosis
11/28/2013US20130316358 Methods of diagnosing disease using overlap extension pcr
1 ... 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 ... 3003